UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 30, 2012
VERENIUM CORPORATION
(Exact name of registrant as specified in its charter)
| Delaware | 000-29173 | 22-3297375 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) | ||
| 3550 John Hopkins Court, San Diego, CA | 92121 | |||
| (Address of principal executive offices) | (Zip Code) | |||
Registrant’s telephone number, including area code: (858) 431-8500
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01 Other Events.
On August 30, 2012 Verenium Corporation (the “Company”) initiated legal action against BP Biofuels North America, LLC (“BP”) in the Supreme Court of the State of New York, County of New York, requesting, among other things, the continuation of certain services provided by BP to the Company for a limited period of time beyond September 2, 2012. The services in question are a subset of those required to be performed by BP for the Company as part of the sale of the Company’s cellulosic biofuels business in September 2010. As sought by the Company in its legal action, on August 30, 2012, the court issued an order requiring BP to continue such services until October 2, 2012.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| VERENIUM CORPORATION | ||||||
| Dated: September 4, 2012 | By: | /s/ James E. Levine | ||||
| Name: | James E. Levine | |||||
| Title: | President and Chief Executive Officer | |||||